Noticias de Eulerpool 4D Molecular Therapeutics

4D Molecular Therapeutics Noticias de Acciones

4D Molecular Therapeutics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de 4D Molecular Therapeutics.

• 28 de mayo ·

  Yahoo
  4DMT to Participate in Upcoming Investor Conferences
• 8 de mayo ·

  Yahoo
  4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
• 5 de mayo ·

  Yahoo
  4DMT to Participate in Upcoming Investor Conferences
• 2 de mayo ·

  Yahoo
  FDA awards RMAT status to 4DMT diabetic macular oedema therapy
• 1 de mayo ·

  Yahoo
  4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME
• 11 de abril ·

  Yahoo
  4DMT Announces New Employment Inducement Grants
• 1 de abril ·

  Yahoo
  Biotech stocks slide as Marks resignation seen being negative for sector
• 27 de marzo ·

  Yahoo
  4DMT to Participate in Upcoming Investor Conferences
• 4 de marzo ·

  Yahoo
  4D Molecular price target lowered to $35 from $39 at RBC Capital
• 28 de febrero ·

  Yahoo
  4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones